BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23293931)

  • 1. Quality of life in Basal cell carcinoma patients in Brazil: a pilot cross sectional study.
    Nunes DH; Fröde TS
    Dermatol Surg; 2013 Apr; 39(4):620-6. PubMed ID: 23293931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
    Berk DR; Ball Arefiev KL; Gladstone HB
    Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of basal cell carcinoma.
    Hakverdi S; Balci DD; Dogramaci CA; Toprak S; Yaldiz M
    Indian J Dermatol Venereol Leprol; 2011; 77(2):251. PubMed ID: 21393972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
    Gibson GE; Ahmed I
    J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
    Yap FB
    Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super giant basal cell carcinoma of the abdominal wall: still possible in the 21st century.
    de Bree E; Laliotis A; Manios A; Tsiftsis DD; Melissas J
    Int J Dermatol; 2010 Jul; 49(7):806-9. PubMed ID: 20618503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
    Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
    J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.
    Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):525-9. PubMed ID: 15056143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
    Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
    J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: results from a multi-institutional retrospective study.
    Fleischer AB; Feldman SR; Barlow JO; Zheng B; Hahn HB; Chuang TY; Draft KS; Golitz LE; Wu E; Katz AS; Maize JC; Knapp T; Leshin B
    J Am Acad Dermatol; 2001 Feb; 44(2):224-30. PubMed ID: 11174379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of surgical margins in Basal cell carcinoma by surgical specialty.
    Bassas P; Hilari H; Bodet D; Serra M; Kennedy FE; García-Patos V
    Actas Dermosifiliogr; 2013 Mar; 104(2):133-40. PubMed ID: 22835227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
    Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
    Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.